Stay updated on Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag in the footer has been updated from v3.5.4 to v3.5.5, indicating a minor update to the page version history. This change does not alter the study details or navigation.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows Revision 3.5.4 in place of Revision 3.5.3, indicating a small update to the page or site template rather than changes to study details.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.5.3 appears in the page footer, replacing the previous Revision: v3.5.2. This reflects a minor maintenance update that does not alter study information.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no visible changes to the study details content.SummaryDifference0.0%

- Check62 days agoChange DetectedMantova, Italy has been replaced with Mantua, Italy in the locations list. The city name is updated to its common English form to improve clarity for participants and searchability.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded Severe myoclonic epilepsy in infancy as a related topic and introduced a Genetic and Rare Diseases Information Center resource in the Resources section.SummaryDifference0.1%

Stay in the know with updates to Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.